Hypoloc Comp

Hydrochlorothiazide and Nebivolol, the active ingredients in Hypoloc Comp, are a thiazide diuretic and a selective β1‑adrenergic blocker presented as oral tablets for oral use. Both components act synergistically to lower blood pressure by reducing plasma volume and decreasing cardiac output. The combination is indicated for the treatment of hypertension in adult patients.

GNH USA supplies Hypoloc Comp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing, regulatory documentation and logistics support for global distribution.

Hypoloc Comp combines a thiazide diuretic and a beta‑blocker to manage elevated blood pressure and related fluid‑retention conditions.

Hypertension: lowers both systolic and diastolic blood pressure, helping achieve target levels. Edema: increases urinary sodium and water excretion, reducing fluid accumulation. Cardiovascular risk management: improves vascular tone and reduces cardiac workload, supporting overall heart health.

Like all antihypertensive agents, Hypoloc Comp may cause adverse reactions that vary in frequency and severity.

Common Side Effects: - Electrolyte imbalance (e.g., low potassium) - Dizziness or light‑headedness - Fatigue - Headache

Serious or Rare Side Effects: - Severe hypotension - Acute kidney injury - Allergic reactions such as rash or angioedema

Before prescribing Hypoloc Comp, clinicians should evaluate patient history and monitor specific parameters. - Renal function: assess creatinine clearance before initiation and periodically during therapy. - Electrolytes: monitor serum potassium and sodium levels, especially when combined with other diuretics. - Diabetes: observe blood glucose as thiazides may affect glycemic control. - Cardiovascular status: use caution in patients with bradycardia or heart block due to β‑blockade. - Pregnancy and lactation: avoid unless benefits outweigh risks; safety data are limited. - Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture and light.

Hypoloc Comp can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may reduce diuretic effect and impair renal function. - Lithium: increased risk of lithium toxicity due to reduced clearance. - Other antihypertensives (e.g., ACE inhibitors, ARBs): may cause excessive blood‑pressure lowering.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: thiazides can raise blood glucose, requiring dose adjustment. - Calcium channel blockers: additive hypotensive effect. - Digoxin: increased serum levels may occur with β‑blockade.